A novel germline BRCA1 mutation identified in a family with hereditary breast and ovarian cancer syndrome.

Wu, Yanmei; Pan, Xiaodong; Dou, Juan; Zhang, Quan; Li, Yuantong; Sheng, Yuan; Liu, Xishui

Wu, Yanmei; Pan, Xiaodong; Dou, Juan; Zhang, Quan; Li, Yuantong; Sheng, Yuan; Liu, Xishui.

Afiliación

Wu Y; Department of Breast and Thyroid Surgery, Changhai Hospital, Navy Medical University, Shanghai, China.
Pan X; Dinfectome Medical Technology Inc., Shanghai, China.
Dou J; Department of Breast and Thyroid Surgery, Changhai Hospital, Navy Medical University, Shanghai, China.
Zhang Q; Department of Breast and Thyroid Surgery, Changhai Hospital, Navy Medical University, Shanghai, China.
Li Y; Department of Biology, Brandeis University, Waltham, MA, USA.
Sheng Y; Department of Breast and Thyroid Surgery, Changhai Hospital, Navy Medical University, Shanghai, China.
Liu X; Department of Breast and Thyroid Surgery, Changhai Hospital, Navy Medical University, Shanghai, China.

Clin Med Insights Oncol ; 15: 11795549211028569, 2021.

Article en En | MEDLINE | ID: mdl-34276234

Palabras clave

BRCA1 mutation; case series; family history; hereditary breast; ovarian and triple negative breast cancer; susceptibility

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Med Insights Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google